These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 22096581)
1. Metabolic patterns and biotransformation activities of resveratrol in human glioblastoma cells: relevance with therapeutic efficacies. Shu XH; Li H; Sun XX; Wang Q; Sun Z; Wu ML; Chen XY; Li C; Kong QY; Liu J PLoS One; 2011; 6(11):e27484. PubMed ID: 22096581 [TBL] [Abstract][Full Text] [Related]
2. SHP2, SOCS3 and PIAS3 Expression Patterns in Medulloblastomas: Relevance to STAT3 Activation and Resveratrol-Suppressed STAT3 Signaling. Li C; Li H; Zhang P; Yu LJ; Huang TM; Song X; Kong QY; Dong JL; Li PN; Liu J Nutrients; 2016 Dec; 9(1):. PubMed ID: 28035977 [TBL] [Abstract][Full Text] [Related]
3. PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling. Zhang P; Yang B; Yao YY; Zhong LX; Chen XY; Kong QY; Wu ML; Li C; Li H; Liu J Gynecol Oncol; 2015 Dec; 139(3):529-35. PubMed ID: 26432044 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of resveratrol sensitivities and metabolic patterns in human and rat glioblastoma cells. Sun Z; Shi S; Li H; Shu XH; Chen XY; Kong QY; Liu J Cancer Chemother Pharmacol; 2013 Nov; 72(5):965-73. PubMed ID: 23989725 [TBL] [Abstract][Full Text] [Related]
5. Identification of metabolic pattern and bioactive form of resveratrol in human medulloblastoma cells. Shu XH; Li H; Sun Z; Wu ML; Ma JX; Wang JM; Wang Q; Sun Y; Fu YS; Chen XY; Kong QY; Liu J Biochem Pharmacol; 2010 May; 79(10):1516-25. PubMed ID: 20105429 [TBL] [Abstract][Full Text] [Related]
6. Distinct sulfonation activities in resveratrol-sensitive and resveratrol-insensitive human glioblastoma cells. Sun Z; Li H; Shu XH; Shi H; Chen XY; Kong QY; Wu ML; Liu J FEBS J; 2012 Jul; 279(13):2381-92. PubMed ID: 22540632 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells. Yu LJ; Wu ML; Li H; Chen XY; Wang Q; Sun Y; Kong QY; Liu J Neoplasia; 2008 Jul; 10(7):736-44. PubMed ID: 18592012 [TBL] [Abstract][Full Text] [Related]
8. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3. Zhang C; Mukherjee S; Tucker-Burden C; Ross JL; Chau MJ; Kong J; Brat DJ Mol Oncol; 2017 Mar; 11(3):280-294. PubMed ID: 28100038 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of NF-κB signaling commits resveratrol-treated medulloblastoma cells to apoptosis without neuronal differentiation. Wen S; Li H; Wu ML; Fan SH; Wang Q; Shu XH; Kong QY; Chen XY; Liu J J Neurooncol; 2011 Aug; 104(1):169-77. PubMed ID: 21161674 [TBL] [Abstract][Full Text] [Related]
11. Low PIAS3 expression in malignant mesothelioma is associated with increased STAT3 activation and poor patient survival. Dabir S; Kluge A; Kresak A; Yang M; Fu P; Groner B; Wildey G; Dowlati A Clin Cancer Res; 2014 Oct; 20(19):5124-32. PubMed ID: 25124686 [TBL] [Abstract][Full Text] [Related]
12. Correlative analyses of the expression levels of PIAS3, p-SHP2, SOCS1 and SOCS3 with STAT3 activation in human astrocytomas. Liu LH; Li H; Cheng XX; Kong QY; Chen XY; Wu ML; Li Y; Liu J; Li C Mol Med Rep; 2017 Feb; 15(2):847-852. PubMed ID: 28035384 [TBL] [Abstract][Full Text] [Related]
13. Cooperative interaction between protein inhibitor of activated signal transducer and activator of transcription-3 with epidermal growth factor receptor blockade in lung cancer. Kluge A; Dabir S; Kern J; Nethery D; Halmos B; Ma P; Dowlati A Int J Cancer; 2009 Oct; 125(7):1728-34. PubMed ID: 19569236 [TBL] [Abstract][Full Text] [Related]
14. The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death. Borghouts C; Tittmann H; Delis N; Kirchenbauer M; Brill B; Groner B Mol Cancer Res; 2010 Apr; 8(4):539-53. PubMed ID: 20371673 [TBL] [Abstract][Full Text] [Related]
15. STAT3 signaling statuses determine the fate of resveratrol-treated anaplastic thyroid cancer cells. Wu J; Li YT; Tian XT; Liu YS; Wu ML; Li PN; Liu J Cancer Biomark; 2020; 27(4):461-469. PubMed ID: 31958078 [TBL] [Abstract][Full Text] [Related]
16. Lumbar puncture-administered resveratrol inhibits STAT3 activation, enhancing autophagy and apoptosis in orthotopic rat glioblastomas. Xue S; Xiao-Hong S; Lin S; Jie B; Li-Li W; Jia-Yao G; Shun S; Pei-Nan L; Mo-Li W; Qian W; Xiao-Yan C; Qing-You K; Peng Z; Hong L; Jia L Oncotarget; 2016 Nov; 7(46):75790-75799. PubMed ID: 27716625 [TBL] [Abstract][Full Text] [Related]
17. Short-term resveratrol exposure causes in vitro and in vivo growth inhibition and apoptosis of bladder cancer cells. Wu ML; Li H; Yu LJ; Chen XY; Kong QY; Song X; Shu XH; Liu J PLoS One; 2014; 9(2):e89806. PubMed ID: 24587049 [TBL] [Abstract][Full Text] [Related]
18. Identification of STAT3-independent regulatory effects for protein inhibitor of activated STAT3 by binding to novel transcription factors. Dabir S; Kluge A; Aziz MA; Houghton JA; Dowlati A Cancer Biol Ther; 2011 Jul; 12(2):139-51. PubMed ID: 21532337 [TBL] [Abstract][Full Text] [Related]
19. PIAS3 suppresses damage in an Alzheimer's disease cell model by inducing the STAT3-associated STAT3/Nestin/Nrf2/HO-1 pathway. Li C; Wang R; Zhang Y; Hu C; Ma Q Mol Med; 2021 Nov; 27(1):150. PubMed ID: 34837964 [TBL] [Abstract][Full Text] [Related]
20. Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3. Dai X; Ahn KS; Kim C; Siveen KS; Ong TH; Shanmugam MK; Li F; Shi J; Kumar AP; Wang LZ; Goh BC; Magae J; Hui KM; Sethi G Mol Oncol; 2015 Apr; 9(4):818-33. PubMed ID: 25624051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]